Genc Bilgicli_2019_Bioorg.Chem_88_102931

Reference

Title : Novel eugenol bearing oxypropanolamines: Synthesis, characterization, antibacterial, antidiabetic, and anticholinergic potentials - Genc Bilgicli_2019_Bioorg.Chem_88_102931
Author(s) : Genc Bilgicli H , Kestane A , Taslimi P , Karabay O , Bytyqi-Damoni A , Zengin M , Gulcin I
Ref : Bioorg Chem , 88 :102931 , 2019
Abstract :

Five oxypropanol amine derivatives that four of them are novel have been synthesized with high yields and practical methods. in vitro antibacterial susceptibility of Acinetobacter baumannii, Pseudomonas aeruginosa, Escherichia coli and Staphylococcus aureus strains to synthesized substances were evaluated with agar well-diffusion method by comparison with commercially available drugs. Most of the bacteria were multidrug resistant. It was concluded that these compounds are much more effective than reference drugs. These eugenol bearing oxypropanolamine derivatives were also effective inhibitors against alpha-glycosidase, cytosolic carbonic anhydrase I and II isoforms (hCA I and II), and acetylcholinesterase (AChE) enzymes with Ki values in the range of 0.80+/-0.24-3.52+/-1.01microM for hCA I, 1.08+/-0.15-3.64+/-0.92microM for hCA II, 5.18+/-0.84-12.46+/-2.08microM for alpha-glycosidase, and 11.33+/-2.83-32.81+/-9.73microM for AChE, respectively.

PubMedSearch : Genc Bilgicli_2019_Bioorg.Chem_88_102931
PubMedID: 31015178

Related information

Citations formats

Genc Bilgicli H, Kestane A, Taslimi P, Karabay O, Bytyqi-Damoni A, Zengin M, Gulcin I (2019)
Novel eugenol bearing oxypropanolamines: Synthesis, characterization, antibacterial, antidiabetic, and anticholinergic potentials
Bioorg Chem 88 :102931

Genc Bilgicli H, Kestane A, Taslimi P, Karabay O, Bytyqi-Damoni A, Zengin M, Gulcin I (2019)
Bioorg Chem 88 :102931